KLIFO
- Company typePrivate
- Founded1994
- HeadquartersGlostrup, Denmark
- Headcount101–250
- GTM typeB2B
- OfferingServices
KLIFO firmographics
Firmographics- Name
- KLIFO
- Legal name
- KLIFO A/S
- Website
- https://klifo.com/
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Where KLIFO is headquartered
LocationHeadquarters
- HQ city
- Glostrup
- HQ country
- Denmark
- HQ region
- Europe
Offices5 records
Markets served
KLIFO business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Drug Development Consultancy Services: Strategic advisory services across drug development including regulatory affairs, CMC, clinical development, pharmacovigilance, quality assurance, and non-clinical development. Provided by senior experts as embedded team members.
- Clinical Trial Supply (CTS) Services: Full-service clinical trial supply including planning, comparator sourcing, packaging, labelling, storage, distribution, and accountability/destruction. Services can be standalone or integrated end-to-end.
- QP and QA Consultancy Services: Qualified Person release, auditing, and quality assurance services available as standalone or part of broader CTS projects.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Project-based pricing tailored to client needs |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
KLIFO product offering
Product offeringCore offering
KLIFO provides strategic drug development consultancy and full-service Clinical Trial Supply (CTS) to pharmaceutical and biotech companies. Its Advisory division delivers senior-expert consulting across CMC, regulatory affairs, clinical development, pharmacovigilance, quality assurance, and non-clinical development, while its CTS division manages the end-to-end clinical supply chain including comparator sourcing, GMP packaging and labelling, temperature-controlled storage, QP release, and global distribution through a managed depot network.
Product overview
KLIFO is a drug development consultancy and full-service Clinical Trial Supply provider operating across two main divisions: KLIFO Advisory and KLIFO CTS. KLIFO Advisory offers strategic drug development consultancy including Drug Development Consulting, CMC Development, Regulatory Affairs, Clinical Development & Operations, Safety & Pharmacovigilance, Quality Assurance, Non-Clinical Development, and managed Veeva Vault services. KLIFO CTS provides end-to-end Clinical Trial Supply services including Comparator and Ancillary Sourcing, Patient Compliant Pack and Label Design, Product Blinding, Packaging and Labelling, Temperature-Controlled Storage, Global Distribution and Depot Management, QP and QA Services, Accountability and Destruction, and Clinical Trial Supply Planning. KLIFO also operates a Graduate Programme to train Clinical Supply Managers. The company operates a new 6,500 sqm state-of-the-art CTS facility in the Copenhagen area, quadrupling capacity and making it the largest facility of its kind in Northern Europe.
Differentiator
Problem solved
Functional benefit
Brands
- KLIFO Advisory: Strategic drug development consultancy providing guidance from early drug development to market, including Drug Development Consulting, CMC development, Regulatory affairs, Clinical Development, Safety & Pharmacovigilance, Quality assurance, and Non-Clinical Development.
- KLIFO Clinical Trial Supply (CTS)
Products and services
- KLIFO Advisory Strategic drug development consultancy providing senior-expert guidance from early drug development to market authorization, combining deep scientific insight with hands-on know-how across Drug Development Consulting, CMC Development, Regulatory Affairs, Clinical Development & Operations, Safety & Pharmacovigilance, Quality Assurance, Non-Clinical Development, and managed Veeva Vault services for pharma and biotech sponsors.
- KLIFO Clinical Trial Supply (CTS) Full-service Clinical Trial Supply providing end-to-end clinical supply chain management including comparator sourcing, GMP packaging and labelling, GxP temperature-controlled storage, QP/QA services, global depot-managed distribution, accountability and destruction, and protocol-specific supply planning for clinical trial sponsors.
- Drug Development Consulting
Quantifiable outcome
- Largest independent CTS provider in Europe
- +3 more outcomes
Companies that use KLIFO
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
KLIFO technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
KLIFO partnerships and signals
Strategic signalScale indicators8 records
Recent moves10 records
Expansion highlights5 records
KLIFO competitors and assessment
Company assessmentDirect peers
- Biocair: Specialist global courier and logistics provider dedicated to clinical trials and life sciences. Comparable to KLIFO on temperature-controlled distribution, IOR services, and clinical supply chain.
- Almac Group: Privately held, Northern Ireland-headquartered provider of integrated clinical trial supply, packaging, and drug development services. Most comparable to KLIFO as a specialist, non-public, end-to-end CTS + consultancy platform serving biotech and pharma.
- PCI Pharma Services: Global clinical trial and commercial packaging, labelling, storage, and distribution provider. Directly comparable on CTS core services and biopharma customer base, with broader global scale than KLIFO.
- Sharp Packaging (part of UDG Healthcare / Clinipace): Specialist clinical trial packaging, labelling, storage, and distribution provider. Closely matches KLIFO CTS on core offering and target customers, though Sharp has a larger US footprint.
- Recipharm: European CDMO with integrated clinical trial material manufacturing, packaging and QP release services. Overlaps with KLIFO's CMC, GMP packaging, and QP services for European biotech sponsors.
- PharmaLex (now part of Cencora/Allergan Aesthetics acquisition by Cencora): Specialist drug development consultancy covering regulatory affairs, CMC, PV, and quality assurance. Closely matches KLIFO Advisory's service portfolio and biotech client base.
- Marken (UPS Healthcare): Global clinical trial logistics and direct-to-patient distribution provider within UPS Healthcare. Direct overlap with KLIFO's global depot, distribution, and DTP services.
Emerging players
- VCLS (Voisin Consulting Life Sciences): Boutique regulatory, clinical, and health economics consultancy serving life sciences clients. Overlaps with KLIFO Advisory on regulatory and clinical development, though without CTS operations.
Broad incumbents
- ICON plc: Top-3 global CRO offering full-service clinical development plus ancillary lab, consulting, and commercialisation services. A larger incumbent competing for the same biopharma clients at scale.
- Charles River Laboratories: Large non-clinical and clinical services provider including drug development consulting, biologics, and supply chain. Broad incumbent competitor for both KLIFO Advisory and selected CTS opportunities.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
KLIFO social profiles
Digital presenceKLIFO compliance and trust
Trust signalCompliance7 records
KLIFO financial estimates
Financial estimateRevenue estimate
Valuation estimate
KLIFO leadership team
Management profileNumber of profiles
Profiles7 records
KLIFO subsidiaries and ownership
Company hierarchySubsidiaries3 records
KLIFO funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
KLIFO M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about KLIFO
What does KLIFO do?
KLIFO provides strategic drug development consultancy and full-service Clinical Trial Supply (CTS) to pharmaceutical and biotech companies. Its Advisory division delivers senior-expert consulting across CMC, regulatory affairs, clinical development, pharmacovigilance, quality assurance, and non-clinical development, while its CTS division manages the end-to-end clinical supply chain including comparator sourcing, GMP packaging and labelling, temperature-controlled storage, QP release, and global distribution through a managed depot network.
Is KLIFO a public or private company?
KLIFO is a private company. It is classified as private equity controlled and is currently operating.
When was KLIFO founded?
KLIFO was founded in 1994. It employs 101 to 250 people.
Where is KLIFO based?
KLIFO is headquartered in Glostrup, Denmark, in the Europe region.
How does KLIFO make money?
Three revenue lines are on record. Drug Development Consultancy Services are the primary driver. The others are clinical Trial Supply (CTS) Services and QP and QA Consultancy Services.
Who are KLIFO's main competitors?
Direct peers on record are Biocair, Almac Group, PCI Pharma Services, Sharp Packaging (part of UDG Healthcare / Clinipace), Recipharm, PharmaLex (now part of Cencora/Allergan Aesthetics acquisition by Cencora) and Marken (UPS Healthcare). VCLS (Voisin Consulting Life Sciences) is listed as an emerging player. Broad incumbents are ICON plc and Charles River Laboratories.
Does KLIFO have an API?
No public API is recorded for KLIFO.